ArticleActa biochimica et biophysica Sinica2026

Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer.

Zhouda Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.